These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 970073)
41. Fertility impairment in females--present status. Prashad M; Seth M; Bhaduri AP Endokrinologie; 1980 Oct; 76(2):192-201. PubMed ID: 7004865 [TBL] [Abstract][Full Text] [Related]
42. [Cervico-vaginal cytology in women fitted with intrauterine devices (197 cases)]. Ancla M; Lacroix C; de Brux J Rev Fr Gynecol Obstet; 1970 Oct; 65(10):585-90. PubMed ID: 5481844 [No Abstract] [Full Text] [Related]
43. [Clinical evaluation of the progesterone T intrauterine device]. Pizarro Orchard E; Gómez Rogers C Rev Chil Obstet Ginecol; 1980; 45(2):87-98. PubMed ID: 6765370 [TBL] [Abstract][Full Text] [Related]
44. Studies on the urinary excretion, biological effects and origin of oestrogens in post-menopausal women. Procopé BJ Acta Endocrinol (Copenh); 1968; 60 Suppl 135():5-110. PubMed ID: 4309973 [No Abstract] [Full Text] [Related]
45. Progesterone administration in patients with absent ovaries. Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713 [TBL] [Abstract][Full Text] [Related]
46. Fertility control by intrauterine release of progesterone. Scommegna A; Avila T; Luna M; Dmowski WP Obstet Gynecol; 1974 May; 43(5):769-79. PubMed ID: 4362728 [TBL] [Abstract][Full Text] [Related]
47. Fertility control by continuous administration of d-Norgestrel, 0.03 mg. Kesserü E; Larrañaga A; Hurtado H; Benavides G Int J Fertil; 1972; 17(1):17-27. PubMed ID: 4362281 [No Abstract] [Full Text] [Related]
48. [Application of intrauterine devices preceded by measurement of the endometrial cavity using a Hollister sound]. Reynoso Ron L; Lozano Balderas M; Lara Ricalde R; Flores Velez A; Aznar Ramos R Ginecol Obstet Mex; 1982 Feb; 50(298):21-4. PubMed ID: 7129181 [TBL] [Abstract][Full Text] [Related]
49. [Various aspects of colpocytology in obstetrics]. GARCIA HERNANDEZ A Tokoginecol Pract; 1956 Dec; 15(147):713-21. PubMed ID: 13422442 [No Abstract] [Full Text] [Related]
50. Effects of hormone therapy on the endometrium. Deligdisch L Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860 [TBL] [Abstract][Full Text] [Related]
51. Interrelations between progesterone and the ovary, pituitary, and central nervous system in the control of ovulation and the regulation of progesterone secretion. Rothchild I Vitam Horm; 1965; 23():210-327. PubMed ID: 5326341 [No Abstract] [Full Text] [Related]
52. [Biological and clinical considerations on intrauterine use of progesterone T for fertility control]. Leone U; Parodi G; Ferrara E; Zaninetta MG; Leone MM Acta Eur Fertil; 1976 Jun; 7(2):145-54. PubMed ID: 970073 [No Abstract] [Full Text] [Related]